Skip to content
Study details
Enrolling now

Effectiveness of Magnesium with Prochlorperazine for Migraines

Wake Forest University Health Sciences
NCT IDNCT06904287ClinicalTrials.gov data as of Apr 2026
Phase

Phase 3

Target enrollment

100

Study length

about 1.5 years

Ages

18+

Locations

1 site in IL

What this study is about

This trial is testing if adding magnesium to prochlorperazine helps lessen migraine pain. It involves adults and will last approximately 546 days. Participants are expected to be enrolled in about 100 people.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Magnesium
  • 2.Take Placebo

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

Therapeutic Nutrients/Minerals/Electrolytes (Acid-Base Activity)

Endpoints

Primary: Mean change in pain - baseline to 30 minutes

Secondary: Emergency Department length of stay, Mean change in pain - baseline to 45 minutes and baseline to 60 minutes, Number of adverse events

Body systems

Neurology